Literature DB >> 109892

L-Dopa feeding suppression: effect on catecholamine neurons of the perifornical lateral hypothalamus.

S F Leibowitz, C Rossakis.   

Abstract

Injection of L-Dopa (0.8--200 nmoles) into the perifornical hypothalamus produced a dose-dependent suppression of feeding in hungry rats. This effect was positively correlated in magnitude with the same effect produced by the catecholamine agonists dopamine and epinephrine, and by the catecholamine-releasing drug amphetamine. L-Dopa's action was partially antagonized by separate injections of the dopaminergic blocker haloperidol (58% blockade) and the beta-adrenergic blocker propranolol (38% blockade). Combined injections of these two antagonists produced a 90% blockade of L-Dopa's effect. Perifornical administration of the dopa decarboxylase inhibitors Ro 4-4602 and MK-486 was also shown to reverse L-Dopas feeding suppression, at doses that enhanced the effect of injected dopamine and epinephrine. On the basis of these findings, L-Dopa appears to suppress food consumption in part through increased catecholamine synthesis, specifically within dopaminergic and adrenergic neurons of the perifornical hypothalamic region.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109892     DOI: 10.1007/bf00432272

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.

Authors:  G Bartholini; A Pletscher
Journal:  J Pharm Pharmacol       Date:  1969-05       Impact factor: 3.765

2.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Effects of chronically administered L-dopa in normal and lesioned cats.

Authors:  P Langelier; A G Roberge; R Boucher; L J Poirier
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

4.  The effects of L-dopa therapy in Parkinson's disease.

Authors:  R A Thompson; J C White; C L Echols
Journal:  Ariz Med       Date:  1970-07

5.  Effects of L-dopa on norepinephrine metabolism in the brain.

Authors:  J P Chalmers; R J Baldessarini; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-03       Impact factor: 11.205

Review 6.  On the role of dopamine in the pathophysiology of anorexia nervosa.

Authors:  V C Barry; H L Klawans
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

7.  Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.

Authors:  A Dolphin; P Jenner; C D Marsden
Journal:  Pharmacol Biochem Behav       Date:  1976-10       Impact factor: 3.533

8.  Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.

Authors:  D A Hutchins; K J Rogers
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

9.  L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

Authors:  M D Yahr; R C Duvoisin; M M Hoehn; M J Schear; R E Barrett
Journal:  Trans Am Neurol Assoc       Date:  1968

10.  Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.

Authors:  S F Leibowitz
Journal:  Brain Res       Date:  1975-11-21       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.